GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » EBITDA Margin %

ACME Laboratories (DHA:ACMELAB) EBITDA Margin % : 17.04% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. ACME Laboratories's EBITDA for the three months ended in Mar. 2024 was BDT1,364 Mil. ACME Laboratories's Revenue for the three months ended in Mar. 2024 was BDT8,004 Mil. Therefore, ACME Laboratories's EBITDA margin for the quarter that ended in Mar. 2024 was 17.04%.


ACME Laboratories EBITDA Margin % Historical Data

The historical data trend for ACME Laboratories's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories EBITDA Margin % Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBITDA Margin %
Get a 7-Day Free Trial 21.88 20.79 18.78 17.73 17.03

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.82 15.19 14.48 24.65 17.04

Competitive Comparison of ACME Laboratories's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACME Laboratories's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's EBITDA Margin % falls into.



ACME Laboratories EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ACME Laboratories's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=4590.343/26947.708
=17.03 %

ACME Laboratories's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=1363.774/8004.48
=17.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACME Laboratories  (DHA:ACMELAB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


ACME Laboratories EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ACME Laboratories (DHA:ACMELAB) Business Description

Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines